• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

止血、血栓形成、再狭窄和动脉粥样硬化中纤维蛋白溶解和凝血系统的分子遗传学。

Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis.

作者信息

Carmeliet P, Collen D

机构信息

Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute of Biotechnology, Leuven, Belgium.

出版信息

Curr Opin Lipidol. 1997 Apr;8(2):118-25. doi: 10.1097/00041433-199704000-00010.

DOI:10.1097/00041433-199704000-00010
PMID:9183550
Abstract

The plasminogen and coagulation systems have been extensively characterized at the biochemical level. Recent gene targeting and gene transfer studies have provided novel insights into their role in the formation of blood vessels and in the pathogenesis of blood vessel disorders including thrombosis, restenosis and atherosclerosis.

摘要

纤溶酶原和凝血系统在生化水平上已得到广泛研究。最近的基因靶向和基因转移研究为它们在血管形成以及包括血栓形成、再狭窄和动脉粥样硬化在内的血管疾病发病机制中的作用提供了新的见解。

相似文献

1
Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis.止血、血栓形成、再狭窄和动脉粥样硬化中纤维蛋白溶解和凝血系统的分子遗传学。
Curr Opin Lipidol. 1997 Apr;8(2):118-25. doi: 10.1097/00041433-199704000-00010.
2
Genetic analysis of the plasminogen and coagulation system in mice.小鼠纤溶酶原与凝血系统的基因分析
Haemostasis. 1996 Oct;26 Suppl 4:132-53. doi: 10.1159/000217292.
3
Gene manipulation and transfer of the plasminogen and coagulation system in mice.小鼠中纤溶酶原和凝血系统的基因操作与转移
Semin Thromb Hemost. 1996;22(6):525-42. doi: 10.1055/s-2007-999055.
4
Factor VII activating protease. Single nucleotide polymorphisms light the way.因子 VII 激活蛋白酶。单核苷酸多态性照亮了道路。
Hamostaseologie. 2011 Aug;31(3):174-6, 177-8. doi: 10.5482/ha-1159. Epub 2011 Jun 8.
5
Genetic interactions between the coagulation and fibrinolytic systems.凝血系统与纤溶系统之间的基因相互作用。
Thromb Haemost. 2001 Jul;86(1):130-7.
6
Activation of coagulation and fibrinolytic system and thrombotic tendency.
Lancet. 2002 Sep 7;360(9335):801-2; author reply 802. doi: 10.1016/s0140-6736(02)09912-9.
7
Haemostatic genetic risk factors in arterial thrombosis.
Thromb Haemost. 2001 Jul;86(1):374-85.
8
Gene targeting and gene transfer studies of the plasminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis.纤溶酶原/纤溶酶系统的基因靶向和基因转移研究:对血栓形成、止血、新生内膜形成和动脉粥样硬化的影响。
FASEB J. 1995 Jul;9(10):934-8. doi: 10.1096/fasebj.9.10.7615162.
9
Physiological consequences of over- or under-expression of fibrinolytic system components in transgenic mice.
Baillieres Clin Haematol. 1995 Jun;8(2):391-401. doi: 10.1016/s0950-3536(05)80274-4.
10
Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system.纤溶酶原/纤溶酶系统生物学作用的基因靶向和基因转移研究
Thromb Haemost. 1995 Jul;74(1):429-36.

引用本文的文献

1
Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.纤连蛋白结合型 PAI-1 通过与成纤维细胞相互作用来预防心脏纤维化的发展。
Lab Invest. 2014 Jun;94(6):633-44. doi: 10.1038/labinvest.2014.51. Epub 2014 Mar 31.
2
Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.白塞病:促凝状态、内皮激活/损伤与疾病活动之间关系的新认识。
Orphanet J Rare Dis. 2013 May 27;8:81. doi: 10.1186/1750-1172-8-81.
3
The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors.
丝氨酸蛋白酶纤溶酶切割NR2A亚基的氨基末端结构域,以解除锌对N-甲基-D-天冬氨酸受体的抑制作用。
J Biol Chem. 2009 May 8;284(19):12862-73. doi: 10.1074/jbc.M805123200. Epub 2009 Feb 24.
4
Genetic background determines response to hemostasis and thrombosis.遗传背景决定了对止血和血栓形成的反应。
BMC Blood Disord. 2006 Oct 5;6:6. doi: 10.1186/1471-2326-6-6.
5
Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1.肿瘤坏死因子α是肥胖相关的纤溶酶原激活物抑制剂1升高的关键成分。
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6902-7. doi: 10.1073/pnas.96.12.6902.